Edit
Viridian Therapeutics, Inc.
http://www.viridiantherapeutics.comLast activity: 13.11.2024
Probably Closed
Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases.
Location: United States, Massachusetts, Waltham
Investors 3
| Date | Name | Website |
| 10.03.2024 | Hercules C... | htgc.com |
| - | MRL Ventur... | mrlv.com |
| 09.11.2022 | Longitude ... | longitudec... |
Mentions in press and media 5
| Date | Title | Description |
| 13.11.2024 | Prevent Blindness Declares Fifth Annual Thyroid Eye Disease Awareness Week as Nov. 18-24, 2024 | Prevent Blindness offers free educational materials for patients and healthcare professionals for its 5th Annual Thyroid Eye Disease Awareness Week. Prevent Blindness provides free educational materials on Thyroid Eye Disease, including a n... |
| 26.07.2021 | VIRIDIAN THERAPEUTICS : APPOINTS KRISTIAN HUMER AS CHIEF FINANCIAL OFFICER AND CHIEF BUSINESS OFFICER (Form 8-K) | VIRIDIAN THERAPEUTICS APPOINTS KRISTIAN HUMER AS CHIEF FINANCIAL OFFICER AND CHIEF BUSINESS OFFICER BOULDER, Colo., July 26, 2021 (GLOBE NEWSWIRE) - Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company advancing new treat... |
| 26.07.2021 | Viridian Therapeutics : Appoints Kristian Humer as Chief Financial Officer and Chief Business Officer | BOULDER, Colo., July 26, 2021 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies, today anno... |
| 15.07.2021 | VIRIDIAN THERAPEUTICS : APPOINTS JENNIFER MOSES, CPA TO THE BOARD OF DIRECTORS AND AS CHAIR OF THE AUDIT COMMITTEE (Form 8-K) | VIRIDIAN THERAPEUTICS APPOINTS JENNIFER MOSES, CPA TO THE BOARD OF DIRECTORS AND AS CHAIR OF THE AUDIT COMMITTEE BOULDER, Colo., July 15, 2021 (GLOBE NEWSWIRE) - Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company advanc... |
| 14.07.2021 | Viridian Therapeutics : Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | BOULDER, Colo., July 14, 2021 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (Nasdaq: VRDN) (“the “Company” or “Viridian”), a biopharmaceutical company advancing new treatments for patients suffering from serious diseases but underserved b... |